W. Alberti

872 total citations
32 papers, 443 citations indexed

About

W. Alberti is a scholar working on Ophthalmology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W. Alberti has authored 32 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Ophthalmology, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W. Alberti's work include Ocular Oncology and Treatments (12 papers), Advanced Radiotherapy Techniques (5 papers) and Cancer-related Molecular Pathways (4 papers). W. Alberti is often cited by papers focused on Ocular Oncology and Treatments (12 papers), Advanced Radiotherapy Techniques (5 papers) and Cancer-related Molecular Pathways (4 papers). W. Alberti collaborates with scholars based in Germany, United States and Belgium. W. Alberti's co-authors include Robert H. Sagerman, Hans‐Peter Beck‐Bornholdt, Thomas Herrmann, V. Svoboda, Horst Jung, John A. Nakhosteen, P. Lommatzsch, W. Havers, W Höpping and Gregory G. Zeller and has published in prestigious journals such as CHEST Journal, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

W. Alberti

31 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Alberti Germany 10 155 146 129 122 100 32 443
J. Pera Spain 16 156 1.0× 198 1.4× 123 1.0× 87 0.7× 82 0.8× 37 503
H. A. van Peperzeel Netherlands 8 60 0.4× 173 1.2× 94 0.7× 134 1.1× 60 0.6× 12 394
K.L. Leonard United States 13 80 0.5× 197 1.3× 154 1.2× 119 1.0× 144 1.4× 56 555
Jorma Heikkonen Finland 16 521 3.4× 60 0.4× 136 1.1× 307 2.5× 97 1.0× 32 797
A.-J. Lemke Germany 10 75 0.5× 35 0.2× 85 0.7× 115 0.9× 93 0.9× 24 345
Lawrence Margolis United States 5 36 0.2× 176 1.2× 108 0.8× 132 1.1× 26 0.3× 8 387
E. Van Limbergen Belgium 8 65 0.4× 98 0.7× 98 0.8× 145 1.2× 73 0.7× 26 372
Teresa Falco Italy 14 31 0.2× 203 1.4× 58 0.4× 157 1.3× 78 0.8× 25 531
Georges F. Hatoum United States 8 25 0.2× 160 1.1× 145 1.1× 78 0.6× 122 1.2× 16 383
Robert Foerster Germany 15 22 0.1× 151 1.0× 158 1.2× 94 0.8× 124 1.2× 40 485

Countries citing papers authored by W. Alberti

Since Specialization
Citations

This map shows the geographic impact of W. Alberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Alberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Alberti more than expected).

Fields of papers citing papers by W. Alberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Alberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Alberti. The network helps show where W. Alberti may publish in the future.

Co-authorship network of co-authors of W. Alberti

This figure shows the co-authorship network connecting the top 25 collaborators of W. Alberti. A scholar is included among the top collaborators of W. Alberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Alberti. W. Alberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alberti, W.. (2015). Acute and Late Side Effects of Radiotherapy for Ocular Disease: An Overview. Frontiers of radiation therapy and oncology. 30. 281–286. 4 indexed citations
2.
Alberti, W., et al.. (2008). Verhinderung ektoper Ossifikationen nach Totalendoprothese des Hüftgelenks durch Strahlentherapie. DMW - Deutsche Medizinische Wochenschrift. 120(28/29). 983–989.
3.
Rades, Dirk, Silke Tribius, Emre F. Yekebas, et al.. (2006). Epoetin alfa improves survival after chemoradiation for Stage III esophageal cancer: Final results of a prospective observational study. International Journal of Radiation Oncology*Biology*Physics. 65(2). 459–465. 22 indexed citations
4.
Wit, Maike de, Annette Raabe, Ralph Buchert, et al.. (2004). Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron‐emission tomography with18F‐fluorodeoxyglucose. International Journal of Radiation Biology. 80(7). 529–539. 5 indexed citations
5.
Sagerman, Robert H. & W. Alberti. (2003). Radiotherapy of Intraocular and Orbital Tumors. Medical radiology. 8 indexed citations
6.
Alberti, W., Gisbert Richard, & Robert H. Sagerman. (2001). Age-related macular degeneration : current treatment concepts. Springer eBooks. 6 indexed citations
7.
Jung, Horst, Hans‐Peter Beck‐Bornholdt, V. Svoboda, W. Alberti, & Thomas Herrmann. (2001). Quantification of late complications after radiation therapy. Radiotherapy and Oncology. 61(3). 233–246. 88 indexed citations
8.
Raabe, Annette, et al.. (2001). Impact of pulmonary metastases of the R1H-tumour on radiation tolerance of rat lung. International Journal of Radiation Biology. 77(9). 947–954. 2 indexed citations
9.
Raabe, Annette, et al.. (2001). Impact of Treatment Acceleration and its Timing on the Response of the Rhabdomyosarcoma R1H of the Rat to Fractionated Irradiation. Strahlentherapie und Onkologie. 177(7). 362–366. 2 indexed citations
10.
Raabe, Annette, et al.. (2000). Influence of dose per fraction and overall treatment time on the response of pulmonary micrometastases of the R1H-tumour to fractionated irradiation. Radiotherapy and Oncology. 56(2). 259–264. 2 indexed citations
11.
Svoboda, V., Hans‐Peter Beck‐Bornholdt, Thomas Herrmann, W. Alberti, & Horst Jung. (1999). Late complications after a combined pre and postoperative (sandwich) radiotherapy for rectal cancer. Radiotherapy and Oncology. 53(3). 177–187. 11 indexed citations
12.
Zölzer, Friedo, et al.. (1995). Changes in S-phase fraction and micronucleus frequency as prognostic factors in radiotherapy of cervical carcinoma. Radiotherapy and Oncology. 36(2). 128–132. 22 indexed citations
13.
Lommatzsch, P., et al.. (1994). Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques. Graefe s Archive for Clinical and Experimental Ophthalmology. 232(8). 482–487. 52 indexed citations
14.
Alberti, W., et al.. (1993). Solid phantom material for the dosimetry of iodine-125 seed ophthalmic plaques. International Journal of Radiation Oncology*Biology*Physics. 26(5). 897–901. 3 indexed citations
15.
Alberti, W., et al.. (1993). Autoradiography for iodine-125 seeds. International Journal of Radiation Oncology*Biology*Physics. 25(5). 881–884. 7 indexed citations
16.
Alberti, W., et al.. (1991). Complications Associated with Brachytherapy Alone or with Laser in Lung Cancer. CHEST Journal. 99(5). 1062–1065. 63 indexed citations
17.
Alberti, W., et al.. (1991). Dosimetry and physical treatment planning for iodine eye plaque therapy. International Journal of Radiation Oncology*Biology*Physics. 20(5). 1087–1092. 8 indexed citations
18.
Messmer, Eli sa beth M., et al.. (1987). Nicht-okulärer, maligner Zweittumor nach Spontanheilung eines Retinoblastoms („Retinom”,„Retinozytom”). Klinische Monatsblätter für Augenheilkunde. 191(10). 299–303. 6 indexed citations
19.
Havers, W., et al.. (1987). The prognosis of retinoblastoma in terms of survival. A computer assisted study. Part II. Ophthalmic Paediatrics and Genetics. 8(2). 85–88. 29 indexed citations
20.
Havers, W., et al.. (1987). The prognosis of retinoblastoma in terms of globe saving treatment. A computer assisted study. Part I. Ophthalmic Paediatrics and Genetics. 8(2). 77–84. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026